115 related articles for article (PubMed ID: 37397992)
1. A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity.
Liang S; Tran E; Du X; Dong J; Sudholz H; Chen H; Qu Z; Huntington N; Babon J; Kershaw N; Zhang ZY; Baell J; Wiede F; Tiganis T
bioRxiv; 2023 Jun; ():. PubMed ID: 37397992
[TBL] [Abstract][Full Text] [Related]
2. A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity.
Liang S; Tran E; Du X; Dong J; Sudholz H; Chen H; Qu Z; Huntington ND; Babon JJ; Kershaw NJ; Zhang ZY; Baell JB; Wiede F; Tiganis T
Nat Commun; 2023 Jul; 14(1):4524. PubMed ID: 37500611
[TBL] [Abstract][Full Text] [Related]
3. PTPN2 elicits cell autonomous and non-cell autonomous effects on antitumor immunity in triple-negative breast cancer.
Goh PK; Wiede F; Zeissig MN; Britt KL; Liang S; Molloy T; Goode N; Xu R; Loi S; Muller M; Humbert PO; McLean C; Tiganis T
Sci Adv; 2022 Feb; 8(8):eabk3338. PubMed ID: 35196085
[TBL] [Abstract][Full Text] [Related]
4. The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity.
Baumgartner CK; Ebrahimi-Nik H; Iracheta-Vellve A; Hamel KM; Olander KE; Davis TGR; McGuire KA; Halvorsen GT; Avila OI; Patel CH; Kim SY; Kammula AV; Muscato AJ; Halliwill K; Geda P; Klinge KL; Xiong Z; Duggan R; Mu L; Yeary MD; Patti JC; Balon TM; Mathew R; Backus C; Kennedy DE; Chen A; Longenecker K; Klahn JT; Hrusch CL; Krishnan N; Hutchins CW; Dunning JP; Bulic M; Tiwari P; Colvin KJ; Chuong CL; Kohnle IC; Rees MG; Boghossian A; Ronan M; Roth JA; Wu MJ; Suermondt JSMT; Knudsen NH; Cheruiyot CK; Sen DR; Griffin GK; Golub TR; El-Bardeesy N; Decker JH; Yang Y; Guffroy M; Fossey S; Trusk P; Sun IM; Liu Y; Qiu W; Sun Q; Paddock MN; Farney EP; Matulenko MA; Beauregard C; Frost JM; Yates KB; Kym PR; Manguso RT
Nature; 2023 Oct; 622(7984):850-862. PubMed ID: 37794185
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity optimization of azepane-containing derivatives as PTPN2/PTPN1 inhibitors.
Zheng J; Zhang Z; Ding X; Sun D; Min L; Wang F; Shi S; Cai X; Zhang M; Aliper A; Ren F; Ding X; Zhavoronkov A
Eur J Med Chem; 2024 Apr; 270():116390. PubMed ID: 38604096
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule PTPN2 Inhibitors Sensitize Resistant Melanoma to Anti-PD-1 Immunotherapy.
Zhu Z; Tang R; Huff S; Kummetha IR; Wang L; Li N; Rana TM
Cancer Res Commun; 2023 Jan; 3(1):119-129. PubMed ID: 36968224
[TBL] [Abstract][Full Text] [Related]
7. PTP1B Is an Intracellular Checkpoint that Limits T-cell and CAR T-cell Antitumor Immunity.
Wiede F; Lu KH; Du X; Zeissig MN; Xu R; Goh PK; Xirouchaki CE; Hogarth SJ; Greatorex S; Sek K; Daly RJ; Beavis PA; Darcy PK; Tonks NK; Tiganis T
Cancer Discov; 2022 Mar; 12(3):752-773. PubMed ID: 34794959
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development.
Katkeviciute E; Hering L; Montalban-Arques A; Busenhart P; Schwarzfischer M; Manzini R; Conde J; Atrott K; Lang S; Rogler G; Naschberger E; Schellerer VS; Stürzl M; Rickenbacher A; Turina M; Weber A; Leibl S; Leventhal GE; Levesque M; Boyman O; Scharl M; Spalinger MR
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33001862
[TBL] [Abstract][Full Text] [Related]
9. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
[TBL] [Abstract][Full Text] [Related]
10. PTPN2 phosphatase deletion in T cells promotes anti-tumour immunity and CAR T-cell efficacy in solid tumours.
Wiede F; Lu KH; Du X; Liang S; Hochheiser K; Dodd GT; Goh PK; Kearney C; Meyran D; Beavis PA; Henderson MA; Park SL; Waithman J; Zhang S; Zhang ZY; Oliaro J; Gebhardt T; Darcy PK; Tiganis T
EMBO J; 2020 Jan; 39(2):e103637. PubMed ID: 31803974
[TBL] [Abstract][Full Text] [Related]
11. Discovery of PVD-06 as a Subtype-Selective and Efficient PTPN2 Degrader.
Hu L; Li H; Qin J; Yang D; Liu J; Luo X; Ma J; Luo C; Ye F; Zhou Y; Li J; Wang M
J Med Chem; 2023 Nov; 66(22):15269-15287. PubMed ID: 37966047
[TBL] [Abstract][Full Text] [Related]
12. PTPN2 regulates the generation of exhausted CD8
LaFleur MW; Nguyen TH; Coxe MA; Miller BC; Yates KB; Gillis JE; Sen DR; Gaudiano EF; Al Abosy R; Freeman GJ; Haining WN; Sharpe AH
Nat Immunol; 2019 Oct; 20(10):1335-1347. PubMed ID: 31527834
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapeutic implications of negative regulation by protein tyrosine phosphatases in T cells: the emerging cases of PTP1B and TCPTP.
Perez-Quintero LA; Abidin BM; Tremblay ML
Front Med (Lausanne); 2024; 11():1364778. PubMed ID: 38707187
[TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer.
Wu C; Spector SA; Theodoropoulos G; Nguyen DJM; Kim EY; Garcia A; Savaraj N; Lim DC; Paul A; Feun LG; Bickerdike M; Wangpaichitr M
Cancer Metab; 2023 May; 11(1):7. PubMed ID: 37226257
[TBL] [Abstract][Full Text] [Related]
15. Probing the molecular basis for potent and selective protein-tyrosine phosphatase 1B inhibition.
Guo XL; Shen K; Wang F; Lawrence DS; Zhang ZY
J Biol Chem; 2002 Oct; 277(43):41014-22. PubMed ID: 12193602
[TBL] [Abstract][Full Text] [Related]
16. PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review.
Song J; Lan J; Tang J; Luo N
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077422
[TBL] [Abstract][Full Text] [Related]
17. Serendipitous discovery of light-induced (In Situ) formation of an Azo-bridged dimeric sulfonated naphthol as a potent PTP1B inhibitor.
Bongard RD; Lepley M; Thakur K; Talipov MR; Nayak J; Lipinski RAJ; Bohl C; Sweeney N; Ramchandran R; Rathore R; Sem DS
BMC Biochem; 2017 May; 18(1):10. PubMed ID: 28569147
[TBL] [Abstract][Full Text] [Related]
18. PTPN2 restrains CD8⁺ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice.
Wiede F; Ziegler A; Zehn D; Tiganis T
J Autoimmun; 2014 Sep; 53():105-14. PubMed ID: 24997008
[TBL] [Abstract][Full Text] [Related]
19. A RP-UFLC Assay for Protein Tyrosine Phosphatases: Focus on Protein Tyrosine Phosphatase Non-Receptor Type 2 (PTPN2).
Duval R; Bui LC; Berthelet J; Dairou J; Mathieu C; Guidez F; Dupret JM; Cools J; Chomienne C; Rodrigues-Lima F
Sci Rep; 2015 Jun; 5():10750. PubMed ID: 26040922
[TBL] [Abstract][Full Text] [Related]
20. Small molecule AZD4635 inhibitor of A
Borodovsky A; Barbon CM; Wang Y; Ye M; Prickett L; Chandra D; Shaw J; Deng N; Sachsenmeier K; Clarke JD; Linghu B; Brown GA; Brown J; Congreve M; Cheng RK; Dore AS; Hurrell E; Shao W; Woessner R; Reimer C; Drew L; Fawell S; Schuller AG; Mele DA
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
